These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 3487691)
1. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Bankiewicz KS; Oldfield EH; Chiueh CC; Doppman JL; Jacobowitz DM; Kopin IJ Life Sci; 1986 Jul; 39(1):7-16. PubMed ID: 3487691 [TBL] [Abstract][Full Text] [Related]
2. Hemiparkinsonism in monkeys following unilateral common carotid artery infusion of MPTP. A study of behavior, biochemistry and histology. Chen SD; Zhou XD; Xu DL; Li GW; Tang QM; Xu XR Chin Med J (Engl); 1991 Sep; 104(9):758-63. PubMed ID: 1935358 [TBL] [Abstract][Full Text] [Related]
3. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology. Imai H; Nakamura T; Endo K; Narabayashi H Brain Res; 1988 Dec; 474(2):327-32. PubMed ID: 3264746 [TBL] [Abstract][Full Text] [Related]
4. Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys. Falardeau P; Bouchard S; Bédard PJ; Boucher R; Di Paolo T Eur J Pharmacol; 1988 May; 150(1-2):59-66. PubMed ID: 3261249 [TBL] [Abstract][Full Text] [Related]
5. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes. Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824 [TBL] [Abstract][Full Text] [Related]
6. Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Clarke CE; Boyce S; Robertson RG; Sambrook MA; Crossman AR J Neurol Sci; 1989 May; 90(3):307-14. PubMed ID: 2786926 [TBL] [Abstract][Full Text] [Related]
7. [Dopa-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated hemiparkinsonian monkeys]. Chen S Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):50-2, 64. PubMed ID: 1591961 [TBL] [Abstract][Full Text] [Related]
8. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys. Rioux L; Frohna PA; Joyce JN; Schneider JS Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972 [TBL] [Abstract][Full Text] [Related]
10. Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density. Joyce JN; Marshall JF; Bankiewicz KS; Kopin IJ; Jacobowitz DM Brain Res; 1986 Sep; 382(2):360-4. PubMed ID: 2944565 [TBL] [Abstract][Full Text] [Related]
11. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys. Guttman M; Yong VW; Kim SU; Calne DB; Martin WR; Adam MJ; Ruth TJ Synapse; 1988; 2(5):469-73. PubMed ID: 3263709 [TBL] [Abstract][Full Text] [Related]
12. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites. Przedborski S; Jackson-Lewis V; Popilskis S; Kostic V; Levivier M; Fahn S; Cadet JL Neurochirurgie; 1991; 37(6):377-82. PubMed ID: 1780015 [TBL] [Abstract][Full Text] [Related]
13. Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP. Brooks BA; Eidelberg E; Morgan WW Brain Res; 1987 Sep; 419(1-2):329-32. PubMed ID: 3499952 [TBL] [Abstract][Full Text] [Related]
14. Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys. Di Paolo T; Bédard P; Daigle M; Boucher R Brain Res; 1986 Aug; 379(2):286-93. PubMed ID: 2427166 [TBL] [Abstract][Full Text] [Related]
15. Developing a stable bilateral model of parkinsonism in rhesus monkeys. Smith RD; Zhang Z; Kurlan R; McDermott M; Gash DM Neuroscience; 1993 Jan; 52(1):7-16. PubMed ID: 8433810 [TBL] [Abstract][Full Text] [Related]
16. A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys. Wolters EC; Kebabian JC; Guttman M; Mak E; Pate BD; Calne DB Neurosci Lett; 1988 Dec; 95(1-3):257-61. PubMed ID: 3265771 [TBL] [Abstract][Full Text] [Related]
17. Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion. Bankiewicz KS; Oldfield EH; Plunkett RJ; Schuette WH; Cogan DG; Hogan N; Zuddas A; Kopin IJ Brain Res; 1991 Feb; 541(1):98-102. PubMed ID: 2029630 [TBL] [Abstract][Full Text] [Related]
18. Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism. Guttman M; Fibiger HC; Jakubovic A; Calne DB J Neurochem; 1990 Apr; 54(4):1329-34. PubMed ID: 1690267 [TBL] [Abstract][Full Text] [Related]
19. Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism. Graham WC; Sambrook MA; Crossman AR Brain Res; 1993 Feb; 602(2):290-303. PubMed ID: 8095431 [TBL] [Abstract][Full Text] [Related]
20. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)]. Doudet D; Gross C; Lebrun-Grandié P; Bioulac B C R Seances Soc Biol Fil; 1985; 179(1):85-97. PubMed ID: 3161601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]